lambeth clinical commissioning collaborative meeting · una dalton presentation no paper items for...

96
Adele Scott, Support to LCCCB, NHS Lambeth, 1 Lower Marsh, Waterloo, London SE1 7NT Tel: 020 3049 4207 e-mail: [email protected] http://www.selondon.nhs.uk/your_local_nhs/lambeth/lambeth_clinical_commis sioning_collaborative_board Lambeth Clinical Commissioning Collaborative Meeting Wednesday 4 th July 2012 From 1.00pm 4.00pm Lambeth Accord 366 Brixton Road, London, SW9 7AA ____________________________________________________________________ Our Mission is to improve the health and reduce health inequalities of Lambeth people and to commission the highest quality health services on their behalf.

Upload: others

Post on 16-Aug-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Adele Scott, Support to LCCCB, NHS Lambeth, 1 Lower Marsh, Waterloo, London SE1 7NT

Tel: 020 3049 4207 e-mail: [email protected] http://www.selondon.nhs.uk/your_local_nhs/lambeth/lambeth_clinical_commis

sioning_collaborative_board

Lambeth Clinical Commissioning

Collaborative Meeting

Wednesday 4th July 2012

From 1.00pm – 4.00pm

Lambeth Accord

366 Brixton Road, London, SW9 7AA

____________________________________________________________________

Our Mission is to improve the health and reduce health

inequalities of Lambeth people and to commission the

highest quality health services on their behalf.

Page 2: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 3: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Page 1 of 4

Meeting of the Lambeth Clinical Commissioning Collaborative Board

(LCCCB) Wednesday 4th July 2012

1.00pm – 4.00pm Lambeth Accord

366 Brixton Road, London, SW9 7AA

Item No

1. Welcome and Introductions

Adrian McLachlan

2. Apologies for Absence Adrian McLachlan

3. Register of Members’ Interests. The LCCCB is asked to note the current register of interests of LCCCB members and relevant BSU Staff.

Adrian McLachlan

Enc A

1.05pm 4. Minutes of the meeting held on 2nd May 2012. The LCCCB is asked to agree the minutes of the meeting held on 2nd May 2012.

Adrian McLachlan

Enc B

1.10pm 5. Matters arising from the minutes of the meeting held on 2nd May 2012. The LCCCB is asked to consider matters arising from the meeting held on 2nd May 2012.

Adrian McLachlan Enc B (2)

1.15pm 6. Chair’s Action The LCCCB is asked to agree the following Chair’s Action for decisions taken on 25th May, 20th and 21st June 2012.

To proceed with Hearing Services AQP, subject to final confirmation of financial impact.

Renewal of Talking Therapies Contracts

2012/13 Operating Plan sign-off (available at: http://www.selondon.nhs.uk/your_local_nhs/lambeth/lambeth_clinical_commissioning_collaborative_board/lcccb_papers_and_meetings)

Adrian McLachlan

Enc C

Enc C (1)

Enc C (2) Enc C (3)

Presentation

1.20pm 7. Organisational Development The LCCCB is asked to receive a presentation on Organisational Development at NHS Lambeth.

Una Dalton Presentation

No Paper

Items For Decision

Age

nda

Page 4: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Page 2 of 4

1.50pm 8. Clinical Commissioning Group Authorisation and Constitution Update The LCCCB is asked to note progress and agree the next steps for CCG application to be submitted on 3rd September 2012.

Una Dalton Enc D

2.05pm 9. Policy/Strategy Development The LCCCB is asked to approve the following Policies / Strategic documents:

1. Organisational Development Plan 2. Equalities Plan 3. Communications and Engagement Strategy 4. Risk Management Strategy 5. Incident management Policy (available at:

http://www.selondon.nhs.uk/your_local_nhs/lambeth/lambeth_clinical_commissioning_collaborative_board/lcccb_papers_and_meetings)

6. Procurement Strategy

Andrew Eyres Enc E

Appendix (A) Appendix (B) Appendix (C) Appendix (D)

Appendix (E)

2.15pm 10. Lambeth Business Plan 2012/13 The LCCCB is asked to agree the 2012/2013 Business Plan.

Una Dalton Enc F

2.20pm 11. Medium-Term Financial Strategy The LCCCB is asked to:

Approve NHS Lambeth’s updated Medium Term Financial Strategy 2012/13 – 2014/15, including investment in initiatives to deliver health goals and QIPP proposals

Note the uncertainties in the financial assumptions in the strategy and arrangements for financial performance and risk management

Christine Caton Enc G

2.30pm 12. Integrated Talking Therapies The LCCCB is asked to approve the award a three year contract for an integrated talking therapies services to a consortium led by to South London and Maudsley NHS Foundation Trust, following a restricted tender process.

Raj Mitra and Ray Walsh

Enc H

Items For Discussion

2.50pm 13. Health & Wellbeing Strategy and Joint Strategic Needs Assessment The LCCCB is asked to recommend:

An interim executive of the shadow Health and Wellbeing Board is set up that provides a steer to the development of the Lambeth JSNA and H&WB strategy

The development of both the JSNA and H&WBS

Ruth Wallis Enc I

Page 5: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Page 3 of 4

is supported with appropriate administrative and programme management support that can coordinate the process for development of both the JSNA and the H&WBS.

The working group is reconstituted to support the production and ownership of the Lambeth JSNA and H&WB strategy, and includes sign up to framework for Health and Wellbeing strategy building on current priorities.

An outline Health & Wellbeing Strategy is developed based on existing Strategic Plan priorities but further work is done to review opportunities for joint strategic needs assessment, the wider determinants and inequality elements of this strategy.

Regular Reports

3.05pm 14. Chair’s Report including Locality Update. The LCCCB is asked to receive the Chair’s report for the period 3rd May 2012 to 3rd July 2012.

Adrian McLachlan

Enc J

3.10pm 15. Managing Director’s Report The LCCCB is asked to receive the Managing Director’s report for the period 3rd May 2012 to 3rd July 2012.

Andrew Eyres Enc K

3.15pm 16. Director of Public Health Report The LCCCB is asked to receive the Public Health Director’s report for the period 3rd May 2012 to 3rd July 2012.

Ruth Wallis Enc L

3.20pm 17. Clinical Network Lead Report. The LCCCB is asked to note progress in the Lambeth Clinical Commissioning Network and recognise the role of the Local Education Training Board and the relationship with commissioners.

Ash Soni Enc M

3.25pm 18. Integrated Governance and Performance Report The LCCCB is asked to note:

1. NHS Lambeth’s new style Integrated Governance & Performance report. 2. NHS Lambeth’s

Outturn against 2011/12 Business Plan objectives and Board Assurance Framework

Lambeth’s outturn position against our National Performance Measures.

Delivery against contract requirements will be published on our website once Q1 2012/13

Andrew Eyres Enc N

3.40pm 19 2011/2012 Financial Position as at May 2012. Christine Caton

Age

nda

Page 6: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Page 4 of 4

19. The LCCCB is asked to:

Note the 2012/13 financial position as Month 2

Note the latest performance against NHS Lambeth’s 2012/13 Cash Management strategy.

Enc O

3.45pm 20. Integrated Care Pilot The LCCCB is asked to note arrangements for ongoing implementation of arrangements to support integrated care in Lambeth through the Lambeth and Southwark Integrated Care Pilot.

Andrew Eyres Enc P

Items For Information

3.50pm 21. To receive for information the following minutes: Enc Q Safer Lambeth Partnership – available at next meeting CYPSP – 21st November 2011 and 29th March 2012 Enc Q (1) and

(1a) LSL and Stakeholder Reference Group Meeting – 1st

May 2012 Enc Q (2)

Adult’s Safeguarding Board – 12th December 2011 Enc Q (3) Children's Safeguarding Working Committee Meeting –

19th December 2011 Enc Q (4)

Research Management Group – 10th January 2012 Enc Q (5) Medicines Management Committee – 11th April 2012 Enc Q (6) Infection Control Committee – available at next meeting SEL Clinical Strategy Group – 26th April 2012 Enc Q (7) LSL Integrated Governance Committee – available at

next meeting

22. Agenda Planning for Meetings in Public. The LCCCB is asked to:

Note the draft agenda items and make suggestions for amendments or additions.

Una Dalton Enc R

Closing Items

3.55pm 23. Any Other Business

Close

Page 7: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

LCCCB Board Report Date 4th July 2012 Report author: Adele Scott, Support to the LCCCB Presented by: Adrian McLachlan, Chair of the LCCCB Queries to: [email protected] 0203 049 4207 Adele Scott Support to the LCCCB

Title: Register Of Members’ Interests

What are the headline messages to consider from this paper?

The Code of Accountability requires all NHS bodies to declare interests, which are relevant and material to this Board. Any changes in interests should be declared at the next Board meeting following the change occurring. During the course of a Board meeting, if a conflict of interest is established, the member concerned should withdraw from the meeting and play no part of the relevant discussion or decision.

Recommendation: The LCCCB is asked to note the current Register of Members’ Interests as at 20th June 2012.

Are there resource implications for revenue, capital, staffing? If yes, please explain.

N/A

Does this require an equality impact assessment (EIA)? If yes, what has been the outcome of the EIA to date? How have the issues raised been addressed in this paper?

N/A

Will the proposals reduce health inequalities? Please explain.

N/A

What has been the scope of PPI in this work? How has feedback been incorporated/actioned to date?

N/A

Have clinicians been engaged in this work?

N/A

What are the key risks to delivery of this work. Are there plans in place to address risks?

N/A

Are there legal issues to consider? N/A

Enc

A -

Reg

iste

r of

Mem

bers

’ Int

eres

ts

Page 8: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 9: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

R

eg

iste

r o

f M

em

be

rs’

Inte

res

ts

La

mb

eth

Cli

nic

al

Co

mm

iss

ion

ing

Co

lla

bo

rati

ve

Bo

ard

(C

onfirm

ed a

s a

ccura

te a

s a

t 20

th J

une 2

012

)

* T

his

is t

he fu

ll re

mune

ratio

n for

an

Exe

cutive D

ire

cto

r o

f L

am

be

th P

CT

in

clu

din

g r

espon

sib

ilities o

ver

and a

bove th

e C

linic

al B

oard

Bo

ard

Me

mb

ers

N

am

e

Tit

le

Inte

res

ts

Re

mu

ne

rati

on

Ad

ria

n

Mc

La

ch

lan

L

CC

CB

Ch

air

, L

am

be

th P

CT

B

oa

rd M

em

be

r

GP

Fa

cili

tato

r a

t T

hre

e B

oro

ug

hs P

rim

ary

He

alth

ca

re T

ea

m

Ch

air

Pri

ma

ry C

are

Su

bsta

nce

Mis

use

Ad

vis

ory

Gro

up

Pa

rtn

er

at

He

the

rin

gto

n G

rou

p P

ractice

wh

ich

in

clu

de

s

me

mb

ers

hip

of

SE

LD

OC

Me

mb

er

of

La

mb

eth

Liv

ing

We

ll C

olla

bo

rative

.

Me

mb

er

of

the

GS

TT

Ch

ari

ty M

ajo

r F

un

din

g C

om

mitte

e

Me

mb

er

NIH

R N

HS

/BIO

PH

AR

MA

CE

UT

ICA

L I

ND

US

TR

Y

R&

D L

EA

DE

RS

HIP

FO

RU

M

£5

5,9

52

pe

r a

nn

um

Jo

hn

Ba

lazs

L

CC

CB

Vic

e C

ha

ir,

Cli

nic

al

Me

mb

er

an

d N

ort

h L

oc

ali

ty

Re

pre

se

nta

tiv

e

Ch

air

of

the

So

uth

Ea

st

Lo

nd

on

Ca

rdia

c a

nd

Str

oke

N

etw

ork

's P

reve

ntio

n W

ork

str

ea

m

Ch

air

No

rth

La

mb

eth

Lo

ca

lity

Ma

rrie

d t

o D

r Je

nn

y L

aw

- C

ha

ir o

f L

am

be

th L

MC

/Pa

rtn

er

at

Ma

wb

ey B

rou

gh

Pa

rtn

er

in t

he

Bin

fie

ld R

oa

d G

en

era

l P

ractice

wh

ich

in

clu

de

s

me

mb

ers

hip

of

SE

LD

OC

£2

7,9

76

pe

r a

nn

um

Pa

tric

ia K

irk

ma

n

LC

CC

B V

ice

Ch

air

, C

lin

ica

l M

em

be

r a

nd

So

uth

Ea

st

Lo

ca

lity

Re

pre

se

nta

tiv

e

GP

Pa

rtn

er

at

Tu

lse

Hill

Pra

ctice

wh

ich

in

clu

de

s

me

mb

ers

hip

of

SE

LD

OC

£2

7,9

76

pe

r a

nn

um

Gil

lia

n E

lls

bu

ry

LC

CC

B C

lin

ica

l M

em

be

r a

nd

S

ou

th E

as

t L

oc

ali

ty

Re

pre

se

nta

tiv

e

GP

Pa

rtn

er

at

Pa

xto

n G

ree

n G

rou

p P

ractice

wh

ich

in

clu

de

s

me

mb

ers

hip

of

SE

LD

OC

GP

Tra

ine

r L

on

do

n D

ea

ne

ry

£2

7,9

76

pe

r a

nn

um

Ru

th J

eff

ery

LC

CC

B C

lin

ica

l M

em

be

r a

nd

S

ou

th W

es

t L

oc

ali

ty

Re

pre

se

nta

tiv

e

Ad

va

nce

d N

urs

e P

ractitio

ne

r a

nd

Le

ad

Nu

rse

at

Dr

Cu

rra

n

an

d P

art

ne

rs

Active

me

mb

er

of

St

Ste

ph

en

's C

/E c

hu

rch

SW

12

, w

ith

clo

se

con

ne

ctio

ns t

o T

he

We

ir L

ink c

om

mu

nity c

entre a

nd

Futu

res

Theatre C

om

pany

(educa

tional d

ram

a).

Vis

itin

g s

pea

ke

r a

t S

t G

eo

rge

's H

osp

ita

l in

th

e in

tere

sts

of

VT

E p

reve

ntio

n.

£2

7,9

76

pe

r a

nn

um

Ra

jiv

e M

itra

L

CC

CB

Cli

nic

al

Me

mb

er

an

d

No

rth

Lo

ca

lity

Re

pre

se

nta

tiv

e

GP

Pa

rtn

er

at

La

mb

eth

Wa

lk G

rou

p P

ractice

wh

ich

in

clu

de

s

me

mb

ers

hip

of

SE

LD

OC

£

27

,97

6 p

er

an

nu

m

Enc

A -

Reg

iste

r of

Mem

bers

’ Int

eres

ts

Page 10: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

R

eg

iste

r o

f M

em

be

rs’

Inte

res

ts

La

mb

eth

Cli

nic

al

Co

mm

iss

ion

ing

Co

lla

bo

rati

ve

Bo

ard

(C

onfirm

ed a

s a

ccura

te a

s a

t 20

th J

une 2

012

)

* T

his

is t

he fu

ll re

mune

ratio

n for

an

Exe

cutive D

ire

cto

r o

f L

am

be

th P

CT

in

clu

din

g r

espon

sib

ilities o

ver

and a

bove th

e C

linic

al B

oard

Na

me

T

itle

In

tere

sts

R

em

un

era

tio

n

La

mb

eth

Wa

lk G

rou

p P

ractice

– C

on

tra

ct

ho

lde

r fo

r L

am

be

th C

om

mu

nity H

ea

da

ch

e C

linic

GP

Tra

ine

r L

on

do

n D

ea

ne

ry

Kin

gs C

olle

ge

Lo

nd

on

Un

de

rgra

du

ate

te

ach

er

Me

mb

er

of

the

Lo

nd

on

Prim

ary

Ca

re R

ese

arc

h N

etw

ork

Re

dm

on

d W

als

h

L

CC

CB

Cli

nic

al

Me

mb

er

an

d

So

uth

We

st

Lo

ca

lity

R

ep

res

en

tati

ve

GP

Prin

cip

al a

t C

lap

ha

m F

am

ily P

ractice

wh

ich

inclu

de

s

me

mb

ers

hip

of

SE

LD

OC

Ch

air

Str

ea

tha

m a

nd

Cla

ph

am

PB

C C

on

so

rtiu

m

Ch

air

Str

ea

tha

m a

nd

Cla

ph

am

He

alth

Ltd

Dire

cto

r P

FG

PS

Ltd

Clin

ica

l D

irecto

r :

SP

MS

Cla

ph

am

NH

S

Me

mb

er

Prim

ary

ca

re S

ub

sta

nce

Mis

use

Prim

ary

Ca

re

Su

pp

ort

Gro

up

Me

mb

er

of

Lo

nd

on

HIV

Exp

ert

Ad

vis

ory

Gro

up

Tu

tor

Fin

al ye

ar

me

dic

al S

tud

en

ts

Me

mb

er

of

na

tio

na

l a

dvis

ory

gro

up

fo

r S

exu

ally

Tra

nsm

itte

d

In

fectio

ns F

ou

nd

atio

n C

ou

rse

Le

ctu

rer

for

KC

H s

exu

ally

Tra

nsm

itte

d I

nfe

ctio

n F

ou

nd

atio

n

Co

urs

e

Me

mb

er

of

the

LS

L H

IV p

reve

ntio

n S

tee

rin

g G

rou

p

Me

mb

er

of

La

mb

eth

Liv

ing

We

ll C

olla

bo

rative

.

£2

7,9

76

pe

r a

nn

um

An

dre

w E

yre

s

Ma

na

gin

g D

ire

cto

r, L

am

be

th

PC

T B

oa

rd M

em

be

r

Ma

rrie

d t

o J

ill L

ocke

tt,

SL

aM

Dire

cto

r o

f B

eh

avio

ura

l a

nd

D

eve

lop

me

nta

l C

AG

La

mb

eth

PC

T S

take

ho

lde

r M

em

be

r o

f S

ou

th L

on

do

n a

nd

M

au

dsle

y N

HS

Fo

un

da

tio

n T

rust

Me

mb

ers

Co

un

cil

Dire

cto

r re

pre

se

ntin

g t

he L

am

be

th,

So

uth

wa

rk a

nd

L

ew

ish

am

PC

T’s

sh

are

ho

ldin

g in

tere

sts

fo

r th

e f

ollo

win

g

LIF

T c

om

pa

nie

s:

Bu

ildin

g B

ette

r H

ea

lth

– L

am

be

th S

ou

thw

ark

Le

wis

ha

m

Lim

ite

d

Bu

ildin

g B

ette

r H

ea

lth

– L

am

be

th S

ou

thw

ark

Le

wis

ha

m

(Ho

ldco

2)

Lim

ite

d

£1

12

, 4

17

.52

* p

er

an

nu

m

Page 11: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

R

eg

iste

r o

f M

em

be

rs’

Inte

res

ts

La

mb

eth

Cli

nic

al

Co

mm

iss

ion

ing

Co

lla

bo

rati

ve

Bo

ard

(C

onfirm

ed a

s a

ccura

te a

s a

t 20

th J

une 2

012

)

* T

his

is t

he fu

ll re

mune

ratio

n for

an

Exe

cutive D

ire

cto

r o

f L

am

be

th P

CT

in

clu

din

g r

espon

sib

ilities o

ver

and a

bove th

e C

linic

al B

oard

Na

me

T

itle

In

tere

sts

R

em

un

era

tio

n

Bu

ildin

g B

ette

r H

ea

lth

– L

am

be

th S

ou

thw

ark

Le

wis

ha

m

(Ho

ldco

3)

Lim

ite

d

Bu

ildin

g B

ette

r H

ea

lth

– L

am

be

th S

ou

thw

ark

Le

wis

ha

m

(Fu

nd

co

2)

Lim

ite

d

Bu

ildin

g B

ette

r H

ea

lth

– L

am

be

th S

ou

thw

ark

Le

wis

ha

m

(Fu

nd

co

3)

Lim

ite

d

Bu

ildin

g B

ette

r H

ea

lth

– L

SL

(F

un

dco

Tra

nch

e 1

) L

imite

d

Build

ing B

ette

r H

ealth

– L

SL (F

undco

Hold

co T

ranch

e 1

) Lim

ited

Bu

ildin

g B

ette

r H

ea

lth

– L

SL

Bid

Co

st

Ho

ldco

Lim

ite

d

Bu

ildin

g B

ette

r H

ea

lth

– L

SL

Bid

Co

st

Lim

ite

d

Ru

th W

all

is

Dir

ec

tor

of

Pu

bli

c H

ea

lth

(jo

int

wit

h L

B L

am

be

th),

La

mb

eth

P

CT

Bo

ard

Me

mb

er

Lo

nd

on

Re

pre

se

nta

tive

– A

D’s

PH

£1

47

, 2

99

.68

* p

er

an

nu

m

Su

e G

all

ag

he

r N

on

Ex

ec

uti

ve

Dir

ec

tor

La

mb

eth

PC

T B

oa

rd M

em

be

r

Se

lf E

mp

loye

d E

xe

cu

tive

Co

ach

, F

acili

tato

r a

nd

D

eve

lop

me

nt

Co

nsu

ltan

t

Wo

rkin

g o

n a

fre

ela

nce

ba

sis

with

va

rio

us o

rga

nis

atio

ns in

th

e N

HS

, p

art

s o

f th

e D

H a

nd

oth

er

se

cto

rs.

Ma

rrie

d t

o a

Co

nsu

lta

nt O

nco

log

ist,

Dr

Ch

ris G

alla

gh

er,

e

mp

loye

d a

t th

e R

oya

l L

on

do

n H

osp

ita

ls N

HS

Tru

st

Vo

lun

tary

wo

rk w

ith

Te

ach

First

Tru

ste

e f

or

Gu

ys a

nd

St

Th

om

as’ C

ha

rity

Sta

kehold

er G

ove

rnor of G

uys

and S

t Thom

as

Hosp

itals

FT

NE

D o

n t

he

NH

S L

ew

ish

am

an

d N

HS

So

uth

wa

rk B

oa

rds

£1

0,5

34

pe

r a

nn

um

Gra

ha

m L

ayle

e

No

n E

xe

cu

tiv

e D

ire

cto

r –

L

am

be

th P

CT

Bo

ard

Me

mb

er

No

n E

xe

cu

tive

Dire

cto

r o

f a

nd

sm

all

sh

are

ho

lde

r in

ET

C

Ve

nu

es L

td

NE

D o

n t

he

NH

S L

ew

ish

am

an

d N

HS

So

uth

wa

rk B

oa

rds

£1

0,5

34

pe

r a

nn

um

Enc

A -

Reg

iste

r of

Mem

bers

’ Int

eres

ts

Page 12: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

R

eg

iste

r o

f M

em

be

rs’

Inte

res

ts

La

mb

eth

Cli

nic

al

Co

mm

iss

ion

ing

Co

lla

bo

rati

ve

Bo

ard

(C

onfirm

ed a

s a

ccura

te a

s a

t 20

th J

une 2

012

)

* T

his

is t

he fu

ll re

mune

ratio

n for

an

Exe

cutive D

ire

cto

r o

f L

am

be

th P

CT

in

clu

din

g r

espon

sib

ilities o

ver

and a

bove th

e C

linic

al B

oard

LC

CC

B C

o-O

pte

d M

em

be

rs a

nd

Att

en

de

es

N

am

e

Tit

le

Org

an

isa

tio

n

Inte

res

ts

Jo

Cle

ary

C

o-O

pte

d M

em

be

r (V

oti

ng

) L

on

do

n B

oro

ug

h o

f L

am

be

th –

E

xe

cu

tiv

e D

ire

cto

r (L

oc

al

Au

tho

rity

)

Ho

no

rary

Tre

asu

rer

an

d T

ruste

e o

f A

sso

cia

tio

n o

f D

ire

cto

rs o

f A

du

lt

So

cia

l S

erv

ice

s;

Ch

air

of

Wo

rkfo

rce

De

ve

lop

me

nt

Ne

two

rk

Bo

ard

Me

mb

er

of

Na

tio

na

l S

kill

s A

ca

de

my f

or

So

cia

l C

are

Me

mb

er

of

So

cia

l W

ork

Re

form

Bo

ard

Me

mb

er

of

the

In

terim

Bo

ard

of

the

Co

lleg

e o

f S

ocia

l W

ork

Ch

air

of

La

mb

eth

Sa

feg

ua

rdin

g A

du

lts P

art

ne

rsh

ip B

oa

rd

Exe

cu

tive

Dir

ecto

r o

f L

.B L

am

be

th

Nic

ola

Kin

gs

ton

C

o-O

pte

d M

em

be

r (n

on

-vo

tin

g)

La

mb

eth

LIN

k

Em

plo

yee o

f NH

S H

am

mers

mith

and F

ulh

am

- P

ublic

Health

Manager

Co

Ch

air o

f L

am

be

th L

INk-

vo

lun

tee

r p

ositio

n

Me

mb

er

of

the

Pa

tie

nt

an

d P

ub

lic A

dvis

ory

Gro

up

(P

PA

G)

for

NH

S

Lo

nd

on

(w

as H

ea

lth

ca

re f

or

Lo

nd

on

).

Fello

w a

t N

ort

h W

est

London C

LAH

RC

Jo

hn

Mo

xh

am

S

ec

on

da

ry C

are

C

o-O

pte

d M

em

be

r (n

on

vo

tin

g)

Kin

g’s

He

alt

h

Pa

rtn

ers

Dire

cto

r o

f C

linic

al S

trate

gy,

Kin

g's

He

alth

Pa

rtn

ers

Pro

fesso

r o

f R

esp

ira

tory

Me

dic

ine

, K

ing

's C

olle

ge

Lo

nd

on

Co

nsu

lta

nt P

hysic

ian

, K

ing

's C

olle

ge

Ho

sp

ita

l

Ch

air

of

Bo

ard

of

Tru

ste

es,

Actio

n o

n S

mo

kin

g a

nd

He

alth

(A

SH

).

Me

mb

er

of

the

GS

TT

Ch

ari

ty M

ajo

r F

un

din

g C

om

mitte

e

Ch

ris

tin

e C

ato

n

Ch

ief

Fin

an

cia

l O

ffic

er

La

mb

eth

PC

T

Nil

He

len

C

ha

rle

sw

ort

h-M

ay

Dir

ec

tor

of

Inte

gra

ted

C

om

mis

sio

nin

g

La

mb

eth

P

CT

/Lo

nd

on

B

oro

ug

h o

f L

am

be

th

Lo

nd

on

Bo

rou

gh

of

La

mb

eth

- D

ivis

ion

al D

ire

cto

r

Un

a D

alt

on

Dir

ec

tor

of

Hu

ma

n

Re

so

urc

es

an

d

Co

rpo

rate

Aff

air

s

La

mb

eth

PC

T

Dire

cto

r o

f H

um

an

Re

so

urc

es,

NH

S S

ou

th E

ast

Lo

nd

on

Clu

ste

r -

2

da

ys a

we

ek.

Page 13: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

R

eg

iste

r o

f M

em

be

rs’

Inte

res

ts

La

mb

eth

Cli

nic

al

Co

mm

iss

ion

ing

Co

lla

bo

rati

ve

Bo

ard

(C

onfirm

ed a

s a

ccura

te a

s a

t 20

th J

une 2

012

)

* T

his

is t

he fu

ll re

mune

ratio

n for

an

Exe

cutive D

ire

cto

r o

f L

am

be

th P

CT

in

clu

din

g r

espon

sib

ilities o

ver

and a

bove th

e C

linic

al B

oard

Mo

ira

Mc

Gra

th

D

ire

cto

r o

f C

are

P

ath

wa

y

Co

mm

iss

ion

ing

La

mb

eth

PC

T

Nil

As

ho

k S

on

i

Cli

nic

al

Ne

two

rk

De

ve

lop

me

nt

Le

ad

La

mb

eth

PC

T

Dire

cto

r o

f C

op

es P

ha

rma

cy L

td

Dire

cto

r o

f S

on

i P

rop

ert

ies (

UK

) L

td.

Ow

ne

r o

f fr

ee

ho

lds o

f 57

0 a

nd

57

2

Str

ea

tha

m H

igh

Ro

ad

, L

on

do

n S

W1

6 3

QQ

.

Ch

air

of

Pfize

r P

ha

rma

cy A

dvis

ory

Bo

ard

Vic

e C

ha

ir o

f L

on

do

n S

ch

oo

l o

f P

ha

rma

cy C

ou

ncil

of

Go

ve

rno

rs

Me

mb

er

of

the

NH

S F

utu

re F

oru

m

Azh

ar

Ala

In

Att

en

da

nc

e a

s

LM

C O

bs

erv

er

LM

C

Pa

rtn

er

with

Gra

fto

n S

qu

are

Su

rge

ry,

Dr

Ho

wa

rd F

ree

ma

n a

nd

P

art

ne

rs in

La

mb

eth

, W

an

dsw

ort

h a

nd

Me

rto

n.

Me

mb

er

La

mb

eth

Lo

ca

l M

ed

ica

l C

om

mitte

e

Lo

ca

lity L

ead

So

uth

We

st

La

mb

eth

Ho

no

rary

Clin

icia

n R

en

al U

nit S

t G

eo

rge

s H

osp

ita

l ,

La

mb

eth

Ou

tre

ach

C

linic

(S

ou

th W

est

Lo

ca

lity)

Dire

cto

r S

tre

ath

am

an

d C

lap

ha

m H

ea

lth

Ltd

Enc

A -

Reg

iste

r of

Mem

bers

’ Int

eres

ts

Page 14: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 15: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

1

Lambeth Clinical Commissioning Collaborative Board (LCCCB) Meeting Wednesday 2nd May 2012

Lambeth Accord

366 Brixton Road, London, SW9 7AA

Minutes of the Meeting

Present: Adrian McLachlan LCCCB Chair AM

Andrew Eyres Managing Director, NHS Lambeth AE

John Balazs Vice Chair and Clinical Member – North Locality

JB

Patricia Kirkman Vice Chair and Clinical Member – South East Locality

PK

Gillian Ellsbury Clinical Member – South East Locality GE

Ruth Wallis Director of Public Health (Joint with LB Lambeth)

RW

Graham Laylee Non Executive Director GL

Sue Gallagher Non Executive Director SG

Ruth Jeffery Clinical Member – South West Locality

RJ

Ray Walsh Clinical Member – South West Locality

RWa

Raj Mitra Clinical Member – North Locality RM

Nicola Kingston LINk Chair: (Co-Opted Board Member)

NK

Jo Cleary Executive Director – Adults and Community Services, LB of Lambeth (Co-Opted Board Member)

JC

John Moxham Kings Health Partners (Co-Opted Board Member)

JM

In Attendance: Adele Scott Support to the LCCCB ASc

Una Dalton Director of HR and Corporate Affairs UD

Helen Charlesworth-May

Director of Integrated Commissioning HCM

Moira McGrath Director of Care Pathway Commissioning

MM

Christine Caton Chief Financial Officer CC

Ash Soni Clinical Commissioning Network Lead

AS

Azhar Ala LMC Representative (Observer) AA

Jane Stopher (Item 15) Director of Diabetes Modernisation Initiative

JS

Enc

B -

Min

utes

- 0

2.05

.12

Page 16: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

2

1. Welcome and Introductions

AM welcomed members of the public to the meeting and introductions were made.

2. Apologies for Absence

There were no apologies noted for this meeting.

3. Declarations of Interest

No declarations of interest were made.

4. Minutes of LCCCB Meeting: 7th March 2012

The minutes were agreed as an accurate record.

5. Matters arising not on the Agenda/ Action Log

Action:

At the 7th March 2012 LCCCB meeting NK shared a patient story highlighting the poor experience of a service user who had, had great difficulty in trying to retrieve the results of a possible cancer diagnosis by telephone. JB confirmed that the issue highlighted by this patient story had been raised directly with the Trust as part of quality review meetings with Senior Managers and Clinicians.

6. Chair’s Action

AM gave a summary of the 2012/13 NHS Lambeth Start Budgets discussed at the LCCCB Seminar held on 21st March 2012. The LCCCB ratified the Chair’s Action taken on the 29th March 2012, approving the 2012/13 Lambeth Start Budgets in line with the proposed Operating Plan and the guidance document, with the agreed changes by Christine Caton, Chief Financial Officer.

PRESENTATION

7. Lambeth Commissioning Strategy Plan 2012/15

AE set out the background and context to the proposed Lambeth Commissioning Strategy Plan 2012/2015, outlining the proposed strategy’s seven priority health goals to best address health improvement for the Lambeth population including a new priority regarding alcohol:

1. Serious Mental Illness (SMI) - to provide more high quality care in the community so people with SMI are less likely to need hospital care.

2. Cardiovascular Disease (CVD) - to reduce illness and death from CVD, reducing the number of people with high blood pressure.

3. Diabetes - to help people manage their diabetes more effectively and help prevent people getting diabetes.

4. HIV - to increase awareness of HIV; promote testing to diagnose HIV in people who do not know they have the virus.

5. Smoking - to reduce the number of people who smoke and boost the number of

Page 17: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

3

smoking quitters. 6. Childhood Obesity - to reduce the numbers of children with obesity and support

others to maintain a healthy weight. 7. Alcohol - to reduce the health impact of alcohol by increasing the number of

frontline staff who can deliver screening brief intervention.

AE drew particular attention to work completed on proposed new equalities objectives as part of the Commissioning Strategy Plan. AE drew Board members attention to the PPI within each of Lambeth’s health programmes. AE noted the importance of the Commissioning Strategy reflecting the LCCCB’s mission to deliver the highest possible healthcare for the people of Lambeth. RJ set out a patient story highlighting the positive experience of a Lambeth resident who had experienced asthma over a number of years and following engagement with local health services became a successful smoking quitter and improved their quality of life. RJ highlighted concern regarding the number of teenagers and young adults currently disengaged from health services and at risk of unprotected health issues. AE cited the aspirations of the Commissioning Strategic Plan QIPP to implement key preventative measures to address this and other challenges. Board members discussed a number of issues:

Achieving borough-wide alignment of skills and attitudes towards identification and early intervention.

Taking every opportunity to assess and identify patient conditions as early as possible.

Male life expectancy in Lambeth increased by four years in the last decade. Healthy Living Pharmacies; Lambeth is the only pilot site currently in London and

doing exceedingly good work across pharmacies. Attracting young people into health services to support improved health. Requests for more patient stories to be brought back to the Board in terms of

complexity and reflection of patient experience across primary, secondary and tertiary care.

Items For Decision

8. Lambeth Commissioning Strategy Plan 2012/15

MM invited feedback on the final draft of the Lambeth Commissioning Strategy Plan 2012/15 and asked the Board to approve the Commissioning Strategic Plan subject to minor drafting changes. MM informed Board members that a short summary articulating Lambeth’s health goals and the objectives of the Commissioning Strategic Plan will be prepared for stakeholders.

Enc

B -

Min

utes

- 0

2.05

.12

Page 18: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

4

The LCCCB approved the Lambeth Commissioning Strategy Plan 2012/13 – 2014/15.

9. Integrated Governance and Performance Report

AE summarised the headlines of the Integrated Governance and Performance report. AE highlighted a number of issues:

The Board Assurance Framework, reporting on delivery against the 2011/12 Business Plan Objectives and our plans in place to mitigate risk particularly in Urgent Care and Referral to Treatment delivery, which continue to be areas of significant challenge for Lambeth and the South-East London sector, through quarter four and into 2012/13.

The performance dashboard, highlighting the latest position against National Performance measures for 2011/12.

AE congratulated the local providers on delivery of the four hour A+E wait standard and highlighted where we have exceeded our required performance such as relating to smoking targets. AE, on behalf of the Board thanked all staff across the NHS on a positive year-end position. AE confirmed Lambeth’s recent award from Unicef for the Baby Friendly Initiative, with regards to work in breastfeeding awareness. Board members discussed:

The current position on 18 week waits Childhood Immunisation rates General provider performance, including cross-borough issues. Low take-up for engagement training. How can this be improved?

RM and NK put forward a suggestion to work together to develop a proposal for a patient engagement programme which could be cross- borough and report back to a future meeting of the LCCCB.

The LCCCB is asked to noted NHS Lambeth’s Integrated Governance and Performance report as at April 2012:

Delivery against 2011/12 Business Plan objectives and Board Assurance Framework

Lambeth’s position against our National Performance Measures, using quarter 4 data where currently available.

Delivery against contract requirements.

10. Children’s Joint Commissioning Framework

PK, Clinical lead for Children, summarised the draft Lambeth Children’s Joint Commissioning Framework. The Framework seeks to establish a common strategic vision, language and approach to commissioning services across the Lambeth Children and Young People’s Strategic Partnership. The Framework sets out the overarching commissioning principles for partners across Lambeth to sign up to and will be underpinned by a number of three year service specific

Page 19: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

5

joint specific priorities:

Special Educational Needs (SEN)

Children Looked After (CLA)

CAMHS

Early Intervention (Lambeth Early Help Offer) PK noted that a range of comments had been received from management and clinical teams and that these would be fed into the final draft version which would be taken to the Children’s Trust board on 25th May 2012. Board Members supported the four priorities and asked for further updates to the Board at future meetings. Action: The LCCCB agreed that approval of the final Children’s Joint Commissioning Framework should be delegated to HCM, member of the Children’s Trust Board, following incorporation of comments.

11. New Health and Wellbeing Arrangements in Lambeth.

JC set out the proposed arrangements in place for the creation of a shadow Health and Wellbeing Board in Lambeth for the period of April 2012 to May 2013. This prepared arrangement had already been approved by the London Borough of Lambeth cabinet. JC thanked partners for their contributions in this work over the past year and set out the ambitions of Lambeth Health and Wellbeing Board including:

Establishing a shared understanding of health and well being outcomes for Lambeth’s population, setting the strategic direction for action to improve and protect health and wellbeing and reduce inequalities.

Ensuring citizens, communities and other stakeholders in Lambeth are fully involved in understanding health and wellbeing outcomes.

Maximising the health and wellbeing outcomes achieved from the resources and assets available within the borough.

Action: The LCCCB agreed that the work programme would be brought back to the LCCCB by JC, RW and AE for discussion. The LCCCB noted the arrangements for establishing a shadow Lambeth Health and Wellbeing Board and the approval of the Cabinet of Lambeth Council on 16th April 2012.

12. Lambeth Safeguarding Adult Partnership Board Annual Paper 2010 – 2011.

JC gave an overview of the Lambeth Safeguarding Adult Partnership Board Annual Report and thanked the LCCCB for their recent seminar time on adult safeguarding with Head of Adult Safeguarding, Adult Social Care and Professional Practice, Clement Guerin. JC noted the effective partnership work taking place in Lambeth and the appointment of Ash Soni as Co-Chair to the Lambeth Safeguarding Adult Partnership Board.

Enc

B -

Min

utes

- 0

2.05

.12

Page 20: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

6

A number of issues were discussed:

Working jointly with Southwark and SLaM to rigorously address mental health and serious mental health illness in Lambeth.

Daytime facilities for vulnerable Adults with learning disabilities. Differentiation between treatment for high functioning adults with learning

disabilities and adults with mental illness. Highlighting the focus on Dementia

JC informed Members of the Clinical Board and Public that Lambeth Adult Social Services Team TOPAZ (Team Offering People Advice and Support) won an award for Adult Services Team of the Year at the Social Worker of the Year Awards 2011. The LCCCB noted the contents of the Annual Report of the Lambeth Safeguarding Adult Partnership Board 2010-2011.

13. Any Qualified Provider (AQP)

MM set out the background on Any Qualified Provider policy detailing proposals for implementation of the three selected service lines across NHS South East London and the required timescales in which to do this. MM confirmed that it is the intention of AQP policy to increase choice and personalisation in NHS-funded services through the introduction of competition into specific services, based on quality. Following an engagement process with clinicians and stakeholders, the service lines selected for implementation across South East London were:

Hearing Services for adults Continence Services for adults Wheelchair Services for children

MM confirmed that the first procurement will be for adult hearing. The specification has been reviewed and revised through the NHS Lambeth Planned Care Programme Board and it is proposed that the process is steered through the Planned Care Programme Board. A number of issues were discussed:

Whether the criteria for assessment of Providers are based on quality or price. National Quality Assessment Centres will assess providers for their ability to

deliver services as specified. How will the AQP reduce health inequalities locally. The policy is intended to increase choice for patients but could increase health

inequalities if pathways or the access process are made more complex. How would we mitigate this risk.

The LCCCB noted progress in implementing AQP across NHS South East London and Lambeth engagement in the work and agreed to proceed with the proposed hearing service procurement through Chair’s action, subject to final assessment of

Page 21: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

7

financial impact though the Planned Care Programme Board.

14. Organisational Development Update

UD updated Board members on progress relating to Organisational Development Plan , informing them that the Health and Social Care Bill gained Royal Assent on 27th March 2012 to become the Health and Social Care Act 2012. UD noted that a range of Clinical Commissioning guidance documents have been published and circulated to Board members including:

Clinical Commissioning Group authorisation: draft guide for applicants Clinical Commissioning Group governing body members: role outlines, attributes

and skills. Best practice resource/practical toolkit – for the appointment of lay members to

clinical commissioning groups ; Clinical Commissioning Group governing body committees: Terms of reference

templates; Model constitution framework for Clinical Commissioning Groups and associated

documentation. Building on the success of the KPMG review session which took place on 18th April 2012, UD confirmed that a refreshed Lambeth Organisational Development Workplan will be developed for the July 2012 meeting and added that a regular update on progress against the agreed OD plan is included in the Integrated Information and Quality Performance report. A number of issues were reviewed:

Patient and Public/Lay representation on the Board. The appointment process to be followed in filling Board appointments The recruitment to the Accountable Officer role, currently underway. The proposed 360 degree process with Local Stakeholders. The timetable to achieve authorisation The process of engagement with practices and partners to develop the

Constitution. The LCCCB:

Noted the latest CCG authorisation guidance

Discussed the next steps for CCG authorisation

Noted the progress on the implementation of the Lambeth CCG Organisational Development Plan

Items for Discussion

15. Diabetes Modernisation Initiative (Transformations Phase)

AM welcomed JS, Programme Director of the Diabetes Modernisation Initiative (DMI) to the meeting. JS gave an overview of the in year priorities for the DMI as it moves into the second phase of its transformation programme, including:

1. Centre of Excellence for Paediatric Diabetes full business case and a new model of care

Enc

B -

Min

utes

- 0

2.05

.12

Page 22: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

8

2. Structured education and self-management 3. Community diabetes models of care 4. Primary Care incentives 5. Partnership working across large scale change

JS confirmed plans for the upcoming year in developing an integrated centre of excellence for paediatric diabetes care across GSTT Kingshealth partners and University Hospitals Lewisham; reconfiguring the structured education and self management opportunities for people with diabetes in the boroughs; and significantly improving the detection and management of diabetes in primary and community care settings. A number of issues were discussed including:

Work developing to pave the transition from pediatric care to adult care. Awareness of teenage disengagement and working with youth services to

implement psycho-social and environmental changes to re-engage children and the need to outreach into schools.

Measures to engage young adults in sexual health and other areas of health services.

Interactive sharing and data availability. The LCCCB noted the in-year priorities for 2012/13 and advised on how the DMI can best engage with LCCCB through the Planned Care Programme Board.

16. 2012/13 Operating Plan and Performance and Financial Risk Assessment

CC gave an overview of the final 2012/13 Operating Plan and Financial Risk Assessment outlining processes for addressing and mitigating risk in year.. CC confirmed that the intention is to use the risk assessment against which to review NHS Lambeth’s in year performance and as a trigger for the development and implementation of in year recovery plans. A number of issues were discussed:

Performance risks Risk around changes and implementation of the Commissioning Support Service. Monitoring quality

The LCCCB noted the performance and financial risks facing NHS Lambeth in 2012/13 and supported the processes for mitigating and managing them in year.

Regular Reports

17. Chair’s Report including Locality Update

The LCCCB received the Chair’s report for the period 8th March 2012 to 1st May 2012. AM thanked Christine Caton and the finance team for all their hard work in achieving financial year-end targets. AM confirmed that the intention to hold all Board meetings in public had begun, with the additional opportunity of an informal meeting with members of the public and LINk immediately before the formal business of each Board.

Page 23: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

9

AM noted a number of public health and addictions events and highlighted the launch of MyHealthBox (https://www.myhealthboxlondon.nhs.uk) on 15th May 2012 a partnership scheme between SLaM, primary care and Microsoft providing a portal for service users to access their health records and additional apps to promote wellbeing.

18. Managing Director’s Report

The LCCCB received the Managing Director’s report for the period 8th March 2012 –1st May 2012. AE highlighted progress with the Clapham One and West Norwood Neighbourhood Resource Centres. AE confirmed the relocation of Clapham Family Practice as part of the Clapham One Project which brings together a library, leisure centre and new health facility located within the newly named Mary Seacole Centre on Clapham High Street and which opened to patients on the 26th March 2012. The NHS Lambeth Business Case for West Norwood reached financial close on 5th April 2012 and work will now proceed on site, with an anticipated opening date to patients of January 2014. AE noted the CQC/OFSTED inspection in April, with official outcome expected to be available at the end of May 2012.

19. Director of Public Health Report

The LCCCB noted the Director of Public Health’s report for the period 8th March 2012 –1st May 2012. RW gave an overview of Public Health work in progress including:

DH Consultation on Plain Packaging of Tobacco Products

Time to Change Campaign

Infection Control –LSL

HIV Review

PMS Review

External Quality Assurance of Diabetes Retinal Screening

Drug Recovery Conference Public Health Transition

RW briefed the Board on Media reports about contraceptive advice in pharmacies. In Lambeth this is for people aged 18 or over and is a successful programme.

20. Clinical Commissioning Network Lead Update

AS gave an update on the progress of the Clinical Commissioning Network noting that interest in the Network from applicants was high with a number of roles appointed and additional roles advertised; including leads for newly qualified doctors and leads for practice nurse education and training. AS confirmed that Stephen Miller, National Lead for Choose and Book and partner at Paxton Green Health centre had recently joined the Clinical Network.

21. 2011/2012 Financial position as at March 2012

CC gave headlines of the financial position as at Month 12, reporting that NHS Lambeth

Enc

B -

Min

utes

- 0

2.05

.12

Page 24: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

10

is underspent by £6.822m as at the end of March 2012, and is forecasting a year-end surplus of £6.605m, as planned and as set out in the PCT’s 2011/12 Integrated Plan. CC reported the achievement of planned surplus and capital targets, noting that the draft accounts will go out on 9th May 2012, to be signed off by the Audit Committee on 29th May 2012, subject to external Audit review. CC confirmed that the paper submitted to the Audit Committee will be circulated at the next LCCCB seminar on 16th May 2012. Action: CC to circulate Finance paper to LCCCB.

22. Integrated Care Pilot

MM gave an overview of the Integrated Care Pilot highlighting the progress being made, including working with Southwark, updating the LCCCB on the next steps including:

Agreeing Local Enhanced Service for Primary Care.

Agreeing memoranda of understanding between partners.

Application of funds linked to contract negotiations. A number of issues were discussed including:

A stronger Primary Care voice as Providers in this work. Links with Living Well Collaborative.

The LCCCB noted:

Arrangements for ongoing implementation of arrangements to support integrated care in Lambeth

Plans for further development work

Emerging governance arrangements for an integrated health and social care system

Items For Information

23. To receive for information the following minutes:

The LCCCB received for information the following minutes:

CYPSP – 23rd January 2012

Children's Safeguarding Working Committee Meeting – 27th March 2012

Medicines Management – 29th February 2012 The following minutes will be available for information at the next LCCCB meeting on 4th July 2012:

Safer Lambeth Partnership

LSL and Stakeholder Reference Group Meeting

Lambeth Adult Safeguarding Board

Research Management Group

Infection Control Committee AM asked LCCCB members to provide any feedback directly to him.

Page 25: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

11

24. Agenda Planning for meetings in Public

The LCCCB noted the agenda planning for public meetings to date. AM spoke to public attendees about the informal meetings with members of the public and LINk now taking place before the formal business of each Board UD invited feedback from LCCCB members on proposals for future agenda items for scheduled Board meetings. Action: All additions or amendments to the agenda planning for meetings in public to be given to UD.

25. Any Other Business

A question was raised by a Lambeth resident regarding the closure of the Effra Day Centre. HCM confirmed that the centre was currently closed for refurbishment and explained that this was taking longer than anticipated as a result of a number difficulties. It is planned that the centre will re-open in September 2012 and that the facilities will be available for use by a broad range of people. HCM agreed to speak to the individual following the meeting.

Enc

B -

Min

utes

- 0

2.05

.12

Page 26: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 27: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Matters Arising Log – 4th

July 2012

DATE ACTION LEAD COMMENTS COMPLETED

07.09.11 OS/NK met to discuss the funding opportunities available and have come to an agreement on this action.

Nicola Kingston

Completed YES

05.11.11 JC to update LCCCB in six months with further details on the work being achieved by Criminal justice and the Mental Health Service.

Jo Cleary JC will present in November 2012.

YES

05.11.12 HCM to feedback to LCCCB on any findings from the SLaM report.

Helen Charlesworth

- May

Agenda Item in November 2011- an action plan has been

drafted.

YES

05.11.11 UD confirmed that work into the catchment of Lambeth serious incidents is due for completion at the end of January.

Una Dalton

Cluster Working Group reviewing with

Borough quality leads.

YES

05.11.11 HCM is facilitating availability of the Annual Report on Adult Safeguarding to the Clinical Board.

Helen Charlesworth

-May

The report was an item on the 2nd May

Board agenda. YES

05.11.11 GE to feedback progress in Gynaecology to JM following her meeting on 14th December 2011.

Gillian Ellsbury

New Gynae Lead to take this forward.

YES

05.11.11 JM to speak with Tobacco Alliance to progress the accurate capture of smoking quitters and discuss any feedback with RW.

John Moxham

JM had attended meetings regarding two Boroughs and

Primary Care and will provide feedback to LCCCB as required.

YES

11.01.12 RW to provide feedback on questions re NHS efficiency.

Ruth Wallis Chlamydia briefing

circulated. YES

11.01.12 AM and AE requested feedback from all LCCCB members on the Development of Commissioning Support Prospectus by 18th January 2012.

Adrian McLachlan

and Andrew Eyres

Completed YES

21.03.12 AE and CC available to discuss Start Budgets with LCCCB members before 4th April 2012 Business Planning Session.

Andrew Eyres and Christine

Caton

Completed YES

Enc

B -

Act

ions

Log

- 0

2.05

.12

Page 28: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Matters Arising Log – 4th

July 2012

DATE ACTION LEAD COMMENTS COMPLETED

21.03.12 All LCCCB Members to provide feedback on the Start Budgets Chair’s Action to Christine by Friday 23rd March 2012.

Christine Caton

Completed YES

18.04.12 GE to act as Negotiation Support lead for the 2012/13 contract and key performance indicators.

Gillian Ellsbury

Completed YES

02.05.12 JB confirmed that the issue highlighted by this patient story had been raised directly with the Trust as part of quality review meetings with Senior Managers and Clinicians.

John Balazs Completed YES

02.05.12 The LCCCB agreed that approval of the final Children’s Joint Commissioning Framework should be delegated to HCM, member of the Children’s Trust Board, following incorporation of comments.

Helen Charlesworth

-May Completed YES

02.05.12 The LCCCB agreed that the work programme would be brought back to the LCCCB by JC, RW and AE for discussion.

Jo Cleary, Ruth Wallis and Andrew

Eyres

Completed YES

02.05.12 CC to circulate Finance paper to LCCCB.

Christine Caton

Completed YES

02.05.12 AM asked LCCCB members to provide any feedback directly to him.

Adrian Eyres Completed YES

02.05.12 All additions or amendments to the agenda planning for meetings in public to be given to UD.

Una Dalton Completed YES

02.05.12 AS to confirm a proposal process for priority recruitment to the Clinical Network and bring back to the LCCCB.

Ash Soni In Progress.

To be included in upcoming report.

YES

30.05.12 ASc to circulate save the date for 26th September 2012 to the Board.

Adele Scott Completed YES

Page 29: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 30: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 31: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 32: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 33: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 34: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 35: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 36: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 37: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 38: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 39: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 40: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 41: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 42: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 43: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 44: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 45: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 46: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 47: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 48: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 49: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 50: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 51: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 52: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 53: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 54: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 55: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 56: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 57: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 58: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 59: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 60: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 61: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 62: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 63: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 64: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 65: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 66: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 67: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 68: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 69: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 70: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 71: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 72: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 73: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 74: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 75: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 76: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 77: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 78: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 79: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 80: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 81: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 82: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 83: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 84: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 85: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

1) C

hairs

Act

ion

AQ

P

Page 86: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 87: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

2) C

hairs

Act

ion

talk

ing

The

rapi

es

Page 88: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 89: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

2) C

hairs

Act

ion

talk

ing

The

rapi

es

Page 90: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 91: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

2) C

hairs

Act

ion

talk

ing

The

rapi

es

Page 92: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 93: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

2) C

hairs

Act

ion

talk

ing

The

rapi

es

Page 94: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation
Page 95: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation

Enc

C (

3) C

hairs

Act

ion

2012

/13

Ope

ratin

g P

lan

Page 96: Lambeth Clinical Commissioning Collaborative Meeting · Una Dalton Presentation No Paper Items For Decision Agenda. Page 2 of 4 1.50 pm 8 . Clinical Commissioning Group Author isation